Welcome to CDC Stacks | HIV Testing: Updates for Laboratories - 23542
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
HIV Testing: Updates for Laboratories


There is no document associated.
Details:
  • Description:
    New testing procedures allow earlier, more accurate detection of HIV infection.

  • Collection(s):
No Related Documents.
You May Also Like:
  1. Nucleic Acid Testing by Public Health Referral Laboratories for Public Health Laboratories Using the U.S. HIV Diagnostic Testing Algorithm
    Personal Author:
    Wesolowski, Laura G.; Wroblewski, Kelly; Bennett, Spencer B.; Parker, Monica M.; Hagan, Celia; Ethridge, Steven F.; Rhodes, Jeselyn; Sullivan, Timothy J.; Ignacio-Hernando, Imelda; Werner, Barbara G.; Owen, S. Michele;
    Published:
    Jan 24 2015
    Source:
    J Clin Virol. 65:6-10.
    Description:
    Background : Many public health laboratories adopting the U.S. HIV laboratory testing algorithm do not have a nucleic acid test (NAT), which is needed when the third-or fourth-generation HIV screening immunoassay is reactive and the antibody-based su...
    File Type:
    Filetype[PDF - 144.61 KB]
  2. New CDC recommendations for HIV testing in laboratories : a step-by-step account of the approach
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    June 2014
    Description:
    CDC’s new recommendations for HIV testing in laboratories capitalize on the latest available technologies to help diagnose HIV infections earlier – as much as 3-4 weeks sooner than the previous testing approach. Early diagnosis is critical since ...
    File Type:
    Filetype[PDF - 387.46 KB]
  3. Guidance for U.S. laboratories testing for Zika virus infection
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    July 26, 2016
    Description:
    Testing of specimens within the United States to determine possible Zika virus infection should be limited to specimens collected from patients meeting CDC’s clinical and epidemiological criteria for testing1. Clinical signs and symptoms associated...
    File Type:
    Filetype[PDF - 421.54 KB]
  4. Guidance for U.S. laboratories testing for Zika virus infection
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    November 16, 2016
    Description:
    Testing of specimens within the United States and U.S. territories to determine possible Zika virus infection should be limited to specimens collected from patients meeting CDC’s clinical and epidemiological criteria for testing1. Clinical signs an...
    File Type:
    Filetype[PDF - 326.39 KB]
  5. Guidance for U.S. laboratories testing for Zika virus infection
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    November 16, 2016
    Description:
    Testing of specimens within the United States and U.S. territories to determine possible Zika virus infection should be limited to specimens collected from patients meeting CDC’s clinical and epidemiological criteria for testing1. Clinical signs an...
    File Type:
    Filetype[PDF - 413.67 KB]